taxonomy (2)
protein (51)
source (4)
structure (2)
composition (1)
disease (3)
reference (4)
site (79)
peptide (82)
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Acid ceramidase / Homo sapiens Q13510
- Alpha-galactosidase A / Homo sapiens P06280
- Alpha-n-acetylgalactosaminidase / Homo sapiens P17050
- Alpha-n-acetylglucosaminidase / Homo sapiens P54802
- Azurocidin / Homo sapiens P20160
- Biglycan / Homo sapiens P21810
- Carboxypeptidase D / Homo sapiens O75976
- Cathepsin D / Homo sapiens P07339
- CD166 antigen / Homo sapiens Q13740
- CD276 antigen / Homo sapiens Q5ZPR3
- Clusterin / Homo sapiens P10909
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-1(XIV) chain / Homo sapiens Q05707
- Complement decay-accelerating factor / Homo sapiens P08174
- Decorin / Homo sapiens P07585
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens Q13444
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens Q9Y5L3
- Fibrillin-1 / Homo sapiens P35555
- Fibronectin / Homo sapiens P02751
- Galectin-3-binding protein / Homo sapiens Q08380
- Gamma-glutamyl hydrolase / Homo sapiens Q92820
- Glucosylceramidase / Homo sapiens P04062
- Golgi apparatus protein 1 / Homo sapiens Q92896
- Golgi membrane protein 1 / Homo sapiens Q8NBJ4
- Immunoglobulin superfamily member 8 / Homo sapiens Q969P0
- Integrin alpha-6 / Homo sapiens P23229
- Integrin alpha-V / Homo sapiens P06756
- Integrin beta-1 / Homo sapiens P05556
- Lactotransferrin / Homo sapiens P02788
- Lysosomal acid phosphatase / Homo sapiens P11117
- Lysosomal alpha-mannosidase / Homo sapiens O00754
- Lysosome membrane protein 2 / Homo sapiens Q14108
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Myelin protein zero-like protein 1 / Homo sapiens O95297
- Myelin protein zero-like protein 2 / Homo sapiens O60487
- Periostin / Homo sapiens Q15063
- Plexin-B2 / Homo sapiens O15031
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Sparc / Homo sapiens P09486
- Tetraspanin-3 / Homo sapiens O60637
- Thrombospondin-1 / Homo sapiens P07996
- Transmembrane 9 superfamily member 3 / Homo sapiens Q9HD45
- Transmembrane glycoprotein NMB / Homo sapiens Q14956
- Vitronectin / Homo sapiens P04004
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Urine (UBERON_0001088)
- BTI-Tn-5B1-4 (CVCL_C190)
Source
- Free / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc
- N-Linked / Hybrid / Structure 3266
Reported structure
- Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
Composition
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Urinary oligosaccharides of fucosidosis. Evidence of the occurrence of X-antigenic determinant in serum-type sugar chains of glycoproteins. (1978 - Nishigaki M, Yamashita K, Matsuda I, Arashima S, Kobata A) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Acid ceramidase / Homo sapiens
- Alpha-galactosidase A / Homo sapiens
- Alpha-n-acetylgalactosaminidase / Homo sapiens
- Alpha-n-acetylglucosaminidase / Homo sapiens
- Azurocidin / Homo sapiens
- Biglycan / Homo sapiens
- Carboxypeptidase D / Homo sapiens
- Cathepsin D / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Complement decay-accelerating factor / Homo sapiens
- Decorin / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibronectin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyl hydrolase / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Golgi membrane protein 1 / Homo sapiens
- Immunoglobulin superfamily member 8 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Integrin alpha-V / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lysosomal acid phosphatase / Homo sapiens
- Lysosomal alpha-mannosidase / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Myelin protein zero-like protein 1 / Homo sapiens
- Myelin protein zero-like protein 2 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Sparc / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane 9 superfamily member 3 / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- VIEAVNGTDAR (11aa)
- WQMNFTVR (8aa)
- EIFVANGTQGK (11aa)
- YETTNK (6aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- AIGFENATQAIGR (13aa)
- ANTTQPGIVEGGQVIK (16aa)
- ENTSDPSIVIAFGR (14aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- GSQWSDIEEFCNR (13aa)
- TCDWIPKPNMSASCK (15aa)
- LPGVCNETMMALWEECKPCLK (21aa)
- TAIFPDIIAQGNASIR (16aa)
- ANIQFGDNGTTISAVSNK (18aa)
- VCSNDNK (7aa)
- AASTYSIDSVSFSYNTGDNTTFPDAEDK (28aa)
- SIDSVSFSYNTGDNTTFPDAEDK (23aa)
- FGCEIENNR (9aa)
- DASINIENMQFIHNGTYICDVK (22aa)
- KDASINIENMQFIHNGTYICDVK (23aa)
- FNPNISWQPIPVHTVPITEDR (21aa)
- GLSFDVSLEVSQGPGLLNDTK (21aa)
- VKVVDRGNGSRPSSPEEVK (19aa)
- IGIYADVGNK (10aa)
- NQTNIER (7aa)
- LNLTTDPK (8aa)
- VYSSANNCTFE (11aa)
- NQSVPISCCR (10aa)
- NGSLFAFR (8aa)
- FVNVTVTPEDQCRPNNVCTGVITR (24aa)
- IVDVNITSEGK (11aa)
- MAAAINATGR (10aa)
- TYTYADTPDDFQIHNFSIPEEDTK (24aa)
- VSVNTANVTIGPQIMEVTVYR (21aa)
- NFTMNEK (7aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- LRNPCTSEQNCTSPFSYK (18aa)
- DFQHIINR (8aa)
- KDNTTVTR (8aa)
- TVIENSTSYEEAK (13aa)
- FPQVNVTK (8aa)
- IININPNK (8aa)
- GSISYINVTR (10aa)
- LNSSTIK (7aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- ELDLTCNITTDR (12aa)
- IIQVVYIHSNNITK (14aa)
- IGPGEPIEIICNVSGAIPPAGR (22aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- LIDNNK (6aa)
- VQPFNVTQGK (10aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- DASSFIAEWQNITK (14aa)
- IANITQGEDQYYIR (14aa)
- IIISPEENVTITCTAENQIER (21aa)
- WNNTGCQALPSQDEGPSK (18aa)
- KENSSEICSNNGECVCGQCVCR (22aa)
- SCVAVTSAQPQNMSR (15aa)
- RHEEGHMINCTCFGQGR (17aa)
- EVNDTLLVNELK (12aa)
- NNSNNFDLNR (10aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- INQTEPVAGNYYPVNTR (17aa)
- QLSCVANQNGSQADCELGNPFK (22aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- VVNSTTGPGEHIR (13aa)
- CDSGFALDSEERNCTDIDECR (21aa)
- KNFTTAPAICHDGK (14aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNESLIDLQE (14aa)
- DNTTCYEFK (9aa)
- NLQVYNATSNSLTVK (15aa)
- MIEAYNITEK (10aa)
- EAGNITTDGYEIIGK (15aa)
- LNGTDPIVAADSK (13aa)
Mass spectrometry observed peptide
-
- Free / No-core (avg mass : 1730.5983)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
- N-Linked / Hybrid (avg mass : 1730.5983)
- Milk (UBERON_0001913)
- Lactotransferrin / Homo sapiens
-
- Hex:5 HexNAc:3 dHex:2 / N-Linked (avg mass : 1730.5983)
- N-Linked / Hybrid / Structure 3266
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Acid ceramidase / Homo sapiens
- Alpha-galactosidase A / Homo sapiens
- Alpha-n-acetylgalactosaminidase / Homo sapiens
- Alpha-n-acetylglucosaminidase / Homo sapiens
- Azurocidin / Homo sapiens
- Biglycan / Homo sapiens
- Carboxypeptidase D / Homo sapiens
- Cathepsin D / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Complement decay-accelerating factor / Homo sapiens
- Decorin / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibronectin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyl hydrolase / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Golgi membrane protein 1 / Homo sapiens
- Immunoglobulin superfamily member 8 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Integrin alpha-V / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Lysosomal acid phosphatase / Homo sapiens
- Lysosomal alpha-mannosidase / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Myelin protein zero-like protein 1 / Homo sapiens
- Myelin protein zero-like protein 2 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Sparc / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane 9 superfamily member 3 / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VIEAVNGTDAR (11aa)
- WQMNFTVR (8aa)
- EIFVANGTQGK (11aa)
- YETTNK (6aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- AIGFENATQAIGR (13aa)
- ANTTQPGIVEGGQVIK (16aa)
- ENTSDPSIVIAFGR (14aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- GSQWSDIEEFCNR (13aa)
- TCDWIPKPNMSASCK (15aa)
- LPGVCNETMMALWEECKPCLK (21aa)
- TAIFPDIIAQGNASIR (16aa)
- ANIQFGDNGTTISAVSNK (18aa)
- VCSNDNK (7aa)
- AASTYSIDSVSFSYNTGDNTTFPDAEDK (28aa)
- SIDSVSFSYNTGDNTTFPDAEDK (23aa)
- FGCEIENNR (9aa)
- DASINIENMQFIHNGTYICDVK (22aa)
- KDASINIENMQFIHNGTYICDVK (23aa)
- FNPNISWQPIPVHTVPITEDR (21aa)
- GLSFDVSLEVSQGPGLLNDTK (21aa)
- VKVVDRGNGSRPSSPEEVK (19aa)
- IGIYADVGNK (10aa)
- NQTNIER (7aa)
- LNLTTDPK (8aa)
- VYSSANNCTFE (11aa)
- NQSVPISCCR (10aa)
- NGSLFAFR (8aa)
- FVNVTVTPEDQCRPNNVCTGVITR (24aa)
- IVDVNITSEGK (11aa)
- MAAAINATGR (10aa)
- TYTYADTPDDFQIHNFSIPEEDTK (24aa)
- VSVNTANVTIGPQIMEVTVYR (21aa)
- NFTMNEK (7aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- LRNPCTSEQNCTSPFSYK (18aa)
- DFQHIINR (8aa)
- KDNTTVTR (8aa)
- TVIENSTSYEEAK (13aa)
- FPQVNVTK (8aa)
- IININPNK (8aa)
- GSISYINVTR (10aa)
- LNSSTIK (7aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- ELDLTCNITTDR (12aa)
- IIQVVYIHSNNITK (14aa)
- IGPGEPIEIICNVSGAIPPAGR (22aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- LIDNNK (6aa)
- VQPFNVTQGK (10aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- DASSFIAEWQNITK (14aa)
- IANITQGEDQYYIR (14aa)
- IIISPEENVTITCTAENQIER (21aa)
- WNNTGCQALPSQDEGPSK (18aa)
- KENSSEICSNNGECVCGQCVCR (22aa)
- SCVAVTSAQPQNMSR (15aa)
- RHEEGHMINCTCFGQGR (17aa)
- EVNDTLLVNELK (12aa)
- NNSNNFDLNR (10aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- INQTEPVAGNYYPVNTR (17aa)
- QLSCVANQNGSQADCELGNPFK (22aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- VVNSTTGPGEHIR (13aa)
- CDSGFALDSEERNCTDIDECR (21aa)
- KNFTTAPAICHDGK (14aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNESLIDLQE (14aa)
- DNTTCYEFK (9aa)
- NLQVYNATSNSLTVK (15aa)
- MIEAYNITEK (10aa)
- EAGNITTDGYEIIGK (15aa)
- LNGTDPIVAADSK (13aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
